Clinical Trials
All Clinical Trials - Page 9 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07083154Phase 3Recruiting
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Mazdutide
- NCT07184086Phase 1Active Not Recruiting
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
Semaglutide
- NCT06441331Phase 1Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Octreotide
- NCT07216651N/ACompleted
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
Semaglutide
- NCT07150975Phase 3Recruiting
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Semaglutide
- NCT06760546Phase 3Recruiting
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Setmelanotide
- NCT07203677N/ACompleted
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
Tirzepatide
- NCT06847399Phase 2Recruiting
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Tirzepatide
- NCT06727331Phase 2Recruiting
Study of Tirzepatide for Recovery and Alcohol Use Management
Tirzepatide
- NCT07188545N/AActive Not Recruiting
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Tirzepatide
- NCT07156591N/ANot Yet Recruiting
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
Semaglutide
- NCT07165158Phase 4Not Yet Recruiting
The Effect of Semaglutide on Bone Health
Semaglutide
- NCT07035704N/ANot Yet Recruiting
Prevent and Reverse Obesity in Children, Adolescents and Young Adults
Semaglutide
- NCT07153471Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Orforglipron
- NCT07152730Phase 1Withdrawn
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Gonadorelin
- NCT07169136N/ARecruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Semaglutide
- NCT07179939Phase 2Not Yet Recruiting
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
Gonadorelin
- NCT07091734Phase 2Recruiting
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Tirzepatide
- NCT07752381N/ACompleted
A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery
BPC-157
- NCT07171723Phase 1/Phase 2Completed
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Semaglutide
- NCT07519213N/ACompleted
Guangdong Endometriosis Retrospective Clinical Cohort
Gonadorelin
- NCT07262957Phase 4Recruiting
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Octreotide
- NCT07616401N/ARecruiting
MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
Abaloparatide
- NCT07141914N/ACompleted
A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
Semaglutide
- NCT07165886Phase 2/Phase 3Recruiting
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Octreotide
- NCT07112872Phase 2Active Not Recruiting
A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetes
Semaglutide
- NCT06922318Phase 2Recruiting
The COSMYC Trial (COmbined Suppression of MYC)
Gonadorelin
- NCT07091500N/ARecruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
Semaglutide
- NCT07121153Phase 1Completed
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
Amycretin
- NCT07115069N/AActive Not Recruiting
Comparison of Body Composition Changes With Weight Loss Interventions
Tirzepatide
- NCT06885736N/ARecruiting
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Tirzepatide
- NCT07160257Phase 1Active Not Recruiting
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
Maridebart-Cafraglutide
- NCT07319286Phase 1/Phase 2Enrolling By Invitation
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
Dulaglutide
- NCT07096908Phase 4Recruiting
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Tirzepatide
- NCT06903923Phase 2Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Semaglutide
- NCT07071974Phase 1Completed
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
Survodutide
- NCT07037433Phase 3Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Maridebart-Cafraglutide
- NCT07097259Phase 1Completed
A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
Gonadorelin
- NCT07804719N/AActive Not Recruiting
Possible Sarcopenia, Sarcopenia, and Functional Status in Patients With Primary Sjögren's Syndrome
Follistatin
- NCT07065539N/ANot Yet Recruiting
GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients
Gonadorelin
- NCT06867835Phase 4Completed
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
PT-141
- NCT07254572Phase 4Recruiting
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
Semaglutide
- NCT06554717Phase 2Recruiting
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Tesamorelin
- NCT07117240Phase 4Enrolling By Invitation
Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
Lixisenatide
- NCT07847593N/ACompleted
Probiotics in Obese Patients Treated With Semaglutide
Semaglutide
- NCT06953882Phase 2Recruiting
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
Gonadorelin
- NCT06861439Phase 4Active Not Recruiting
GLP-1s to Enhance Lasting Optimal Weight
Tirzepatide
- NCT07064486Phase 3Recruiting
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
Semaglutide
- NCT06759701EARLY_Phase 1Recruiting
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
Tirzepatide
- NCT07042672N/ARecruiting
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
Tirzepatide